Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Oncoimmunology|February 16, 2017
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200Muhammad Zaeem Noman, Bassam Janji, Abderemane Abdou, et al.
Oncoimmunology|April 18, 2025
Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse modelMuhammad Zaeem Noman, Martyna Szpakowska, Malina Xiao, et al.
Methods in Cell Biology|January 17, 2025
Quantitative pre-clinical imaging of hypoxia and vascularity using MRI and PETGeorgia Kanli, Selma Boudissa, Radovan Jirik, et al.
Oncoimmunology|November 21, 2015
miR-181a modulates acute myeloid leukemia susceptibility to natural killer cellsArash Nanbakhsh, Géraldine Visentin, Daniel Olive, et al.
Frontiers in Immunology|June 20, 2022
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-BGiulia D'Uonnolo, Nathan Reynders, Max Meyrath, et al.
International Journal of Molecular Sciences|June 9, 2018
Inhibition of HIF1α-Dependent Upregulation of Phospho-l-Plastin Resensitizes Multiple Myeloma Cells to Frontline TherapyManon Bosseler, Vanessa Marani, Angelina Broukou, et al.
Cells|June 21, 2019
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor MicroenvironmentNathan Reynders, Dayana Abboud, Alessandra Baragli, et al.
Cancer Letters|May 29, 2019
Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpointsAudrey Lequeux, Muhammad Zaeem Noman, Malina Xiao, et al.
Scientific Reports|July 7, 2018
Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2Céline Hoffmann, Xianqing Mao, Joshua Brown-Clay, et al.
Pageof 10